S. Paternoster

Pancreatic cancer tumorspheres are cancer stem-like cells with increased chemoresistance and reduced metabolic potential.

M. Falasca, A. Domenichini, A. Adamska, 2019, Advances in biological regulation.

Photophysical and Biological Properties of Iridium Tetrazolato Complexes Functionalised with Fatty Acid Chains

D. Brooks, M. Falasca, A. Ranieri, 2020, Inorganics.

Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase Phosphorylation.

M. Falasca, B. Skelton, P. Simpson, 2017, Chemistry.

Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119.

M. Rosenkilde, P. Newsholme, M. Falasca, 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.

The intricate relationship between diabetes, obesity and pancreatic cancer.

M. Falasca, S. Paternoster, 2019, Biochimica et biophysica acta. Reviews on cancer.

Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1

M. Falasca, S. Paternoster, 2018, Front. Endocrinol..

Pharmacological and structure-activity relationship studies of oleoyl-lysophosphatidylinositol synthetic mimetics.

M. Rosenkilde, M. Falasca, D. Keating, 2021, Pharmacological research.

Targeting the adipose tissue to fight prostate cancer.

M. Falasca, S. Paternoster, 2019, Translational andrology and urology.

Oleoyl-lysophosphatidylinositol enhances glucagon-like peptide-1 secretion from enteroendocrine L-cells through GPR119.

M. Rosenkilde, P. Newsholme, M. Falasca, 2018, Biochimica et biophysica acta. Molecular and cell biology of lipids.

Editorial: Gastrointestinal Hormones

M. Falasca, D. Keating, S. Paternoster, 2019, Front. Endocrinol..